Trump administration fast-tracks ibogaine research for PTSD
Top Story
Archived
•
November 12, 2026
•
2 views
The Trump administration announced on Thursday a multi-department investment in fast-tracking research for the psychotropic drug ibogaine to treat post-traumatic stress disorder and other serious mental illnesses. Health and Human Services Secretary Robert F. Kennedy Jr. announced a more than $25 million investment from his department, along with the Department of Veterans Affairs, to speed […]
Source: Washington Examiner | https://www.washingtonexaminer.com/feed - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!


